x

mRNA

A screenshot of the Atlanta Jewish Times story, "After COVID, Cancer Vaccine on Horizon," which includes Coulter Department Regents Professor Mark Borodovsky.
Borodovsky Explains Vaccine Advances to Atlanta Jewish Times

The Atlanta Jewish Times explored how the same technology that led to rapid development of Covid-19 vaccines could also lead to vaccines for cancer, turning to Regents Professor Mark Borodovsky for his expertise.
Borodovsky Explains Vaccine Advances to Atlanta Jewish Times

Regents Professor shares insight on mRNA technology and genome sequencing
9 Things to Know About the Covid-19 Vaccines

Two researchers in the Coulter Department of Biomedical Engineering work with the components that make up the vaccine and say they’re safe and effective.
Phil Santangelo is using an NIH grant to develop an HIV vaccine.
Santangelo Using NIH Grant to Prevent HIV in Women

BME researcher developing low-cost, self-applied, durable system based on mRNA
Researcher Daryll Vanover works with the nebulizer he adapted to test a new mRNA-based treatment for flu and Covid-19. The team used mRNA technology to code for a protein called Cas13a that destroys parts of the RNA genetic code that viruses use to replicate in cells in the lungs. It was developed by researchers in Philip Santangelo’s lab in the Wallace H. Coulter Department of Biomedical Engineering. (Photo Courtesy: Daryll Vanover)
Easy-to-deliver mRNA treatment shows promise for stopping flu and Covid-19 viruses

The treatment uses a type of CRISPR to target viral RNA and appears to stop replication of both viruses in the lungs.
3D super-resolution microscopy cross-sectional image showing how the engineered antibody aPali works: aPali (green) is expressed on the cell surface and stops RSV particles (pink) from entering the cell.
Delivering Antibodies via mRNA Could Prevent RSV Infection

Getting antibodies directly to the lungs protected mice from the virus.